Company intelligence
Natera
We are a global leader in cell-free DNA and precision medicine.
About Natera
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, organ health, and rare disease. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. Please be advised that Natera will only reach out to candidates with an @natera.com email domain. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/
Verified activity
Signals from Natera
13 published signals
Presence & Recognition
Natera hosted a case-based discussion featuring two GU oncology experts on integrating Signatera ctDNA testing into renal cell carcinoma and muscle-invasive bladder cancer management.
Reported by Natera
Presence & Recognition
Natera announced that Cait Mallinson is joining the company Wednesday to show how AI-enabled Talent Operations works inside ElevenLabs.
Reported by Jason Miller
Presence & Recognition
Natera was featured on Mad Money with Jim Cramer
Reported by Solomon Moshkevich
Presence & Recognition
Natera was featured last night on Mad Money with Jim Cramer, covering the company's evolution, recent milestones, strong Q2 earnings, and MRD testing runway.
Reported by Natera
People
Natera is hiring an AI Machine Learning Scientist to work on multimodal AI.
Reported by Joe Daccache, Ph.D.
Operations & Supply
Natera held a sustainability team meeting to recalibrate next projects, ask for emissions reductions, and brainstorm work.
Reported by Casey Stock
Presence & Recognition
Natera featured Osama Khan, MD as a guest speaker on the GUS Medical & Veterinary Schools MedTalks series exploring pathology transforming cancer care and improving outcomes.
Reported by Osama Khan, MD
Presence & Recognition
Natera is hosting an upcoming webinar titled Beyond the data: Navigating exome and genome results in general practice, designed specifically for non-genetics clinicians.
Reported by Natera
Operations & Supply
Natera cut the ribbon on its newest campus in East Denver.
Reported by Casey Stock
Presence & Recognition
Natera is supporting the Lymphoma Research Foundation running team at a RunDisney event this fall to raise awareness and critical funds for lymphoma research.
Reported by Sharon Mexal, PhD, MB (ASCP), CGMBS
People
Natera is hiring Inside Sales Representatives for a fully remote, 100% commission-based role in PST, MST, or CST.
Reported by Jennifer James, MBA
Research & Knowledge
Natera published a new public publication in Blood Neoplasia representing an important advancement in lymphoma ctDNA-MRD testing.
Reported by Natera
Partnerships
Natera announced a national partnership with Susan G. Komen to sponsor the 2026 Premier National Series events.
Reported by Natera